So the skin rationale is the best-supported of any goal here, while still involving a significant leap from topical data to injected blends
Protection against ongoing injury from NSAIDs, corticosteroids, and other damaging agents extends the peptides utility
In simpler terms, it works by: Significantly reducing appetite and cravings through central action in the brain
GHK-Cu has accumulated one of the broadest and most well-established research profiles of any small peptide in regenerative and skin biology science: Collagen and ECM Research: Studies have consistently documented GHK-Cus stimulatory effects on collagen synthesis in fibroblast models, with research reporting upregulation of collagen type I, III, and IV production alongside modulation of MMP and TIMP activity establishing GHK-Cu as one of the most well-characterised collagen-stimulating peptides in dermatological and tissue biology research
Its five-residue structure includes non-standard and D-amino-acid residues: Aib-His-D-2-Nal-D-Phe-Lys-NH 2
Nicotiana tabacum overexpressing -ECS exhibits biotic stress tolerance likely through NPR1- dependent salicylicacid-mediated pathway